Keywords: china, nscl, cancer, drug, market, set, double

China's NSCL cancer drug market set to double from 2008 to 2013

Article | 11 May 2009

Print This

The non-small cell lung cancer drug market in China will more than double by 2013, growing from $307.0 million in 2008 to $648.0 million ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in